Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN.
Department of Surgery, Saint Louis University School of Medicine, St. Louis, MO.
Am J Transplant. 2018 Jan;18 Suppl 1:464-503. doi: 10.1111/ajt.14564.
Medicare costs vary for solid organ transplant recipients by outcome: survival with graft function, survival with graft failure, and death. Average per-person per-year reimbursement was $75 thousand for kidney recipients who survived the first year posttransplant with a functioning graft, $171 thousand for those who required a return to dialysis or retransplant, and $350 thousand for those who died with function. For pancreas recipients: $105 thousand for those who survived the first year with a functioning graft, $120 thousand for those who survived pancreas failure, and $443 thousand for those who died with function. For liver recipients: $154 thousand for those who survived with a functioning graft, $388 thousand for those who required retransplant, and $740 thousand who died with function. For intestine recipients: $301 thousand for those who survived with a functioning graft and $1 million for those who died with function. For heart recipients: $272 thousand for those who survived with a functioning graft and $1.2 million for those who died with function. For lung recipients: $196 thousand for those who survived with a functioning graft, $642 thousand for those who required retransplant, and $761 thousand for those who died with function.
移植物功能存活、移植物失败存活和死亡。第一年移植后存活且移植物功能正常的肾移植受者，每人每年的平均报销金额为 7.5 万美元；需要重新透析或再次移植的受者为 17.1 万美元；功能正常但死亡的受者为 35 万美元。胰腺移植受者：存活且移植物功能正常的受者为 10.5 万美元；胰腺衰竭存活的受者为 12 万美元；功能正常但死亡的受者为 44.3 万美元。肝移植受者：存活且移植物功能正常的受者为 15.4 万美元；需要再次移植的受者为 38.8 万美元；功能正常但死亡的受者为 74 万美元。肠移植受者：存活且移植物功能正常的受者为 30.1 万美元；功能正常但死亡的受者为 100 万美元。心脏移植受者：存活且移植物功能正常的受者为 27.2 万美元；功能正常但死亡的受者为 120 万美元。肺移植受者：存活且移植物功能正常的受者为 19.6 万美元；需要再次移植的受者为 64.2 万美元；功能正常但死亡的受者为 76.1 万美元。
